Allogene Therapeutics (ALLO) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Allogene Therapeutics | 521.43 Mn | 521.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.66% |
| Dec 31, 2025 | -1.72% |
| Sep 30, 2025 | 9.94% |
| Jun 30, 2025 | 0.94% |
| Mar 31, 2025 | 5.73% |
| Dec 31, 2024 | -0.31% |
| Sep 30, 2024 | 33.05% |
| Jun 30, 2024 | -14.96% |
| Mar 31, 2024 | 15.57% |
| Dec 31, 2023 | 3.61% |
| Sep 30, 2023 | 5.38% |
| Jun 30, 2023 | -4.40% |
| Mar 31, 2023 | -0.87% |
| Dec 31, 2022 | 15.40% |
| Sep 30, 2022 | -12.59% |
| Jun 30, 2022 | -9.23% |
| Mar 31, 2022 | -12.30% |
| Dec 31, 2021 | 17.30% |
| Sep 30, 2021 | 9.45% |
| Jun 30, 2021 | 16.49% |
| Mar 31, 2021 | 14.37% |
| Dec 31, 2020 | 4.76% |
| Sep 30, 2020 | 12.86% |
| Jun 30, 2020 | -82.51% |
| Mar 31, 2020 | -3.06% |
| Dec 31, 2019 | 4.58% |
| Sep 30, 2019 | 0.23% |
| Jun 30, 2019 | 52.34% |
| Mar 31, 2019 | -133.12% |
| Dec 31, 2018 | 19.17% |